BioCryst Pharmaceuticals (MEX:BCRX) FCF Margin % : -4.48% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is BioCryst Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioCryst Pharmaceuticals's Free Cash Flow for the three months ended in Dec. 2024 was MXN-123 Mil. BioCryst Pharmaceuticals's Revenue for the three months ended in Dec. 2024 was MXN2,743 Mil. Therefore, BioCryst Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2024 was -4.48%.

As of today, BioCryst Pharmaceuticals's current FCF Yield % is -2.96%.

The historical rank and industry rank for BioCryst Pharmaceuticals's FCF Margin % or its related term are showing as below:

MEX:BCRX' s FCF Margin % Range Over the Past 10 Years
Min: -761.41 Med: -128.32 Max: -10.47
Current: -10.47

During the past 13 years, the highest FCF Margin % of BioCryst Pharmaceuticals was -10.47%. The lowest was -761.41%. And the median was -128.32%.

MEX:BCRX's FCF Margin % is ranked worse than
74.65% of 990 companies
in the Drug Manufacturers industry
Industry Median: 0.9 vs MEX:BCRX: -10.47

BioCryst Pharmaceuticals FCF Margin % Historical Data

The historical data trend for BioCryst Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCryst Pharmaceuticals FCF Margin % Chart

BioCryst Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-761.41

-91.97

-60.26

-29.36

-11.79

BioCryst Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-10.14	-58.13	-1.39	6.99	-4.48

Competitive Comparison of BioCryst Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, BioCryst Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioCryst Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioCryst Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioCryst Pharmaceuticals's FCF Margin % falls into.

BioCryst Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioCryst Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-1108.356	/	9399.914
	=	-11.79 %

BioCryst Pharmaceuticals's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-122.799	/	2743.234
	=	-4.48 %

BioCryst Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioCryst Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCryst Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioCryst Pharmaceuticals Inc (MEX:BCRX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

BCRX:USA BO1:Germany

Address

4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703

Website

https://www.biocryst.com

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.